Sumampong, Ermelito .

HRN: 20-58-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/18/2026
06/24/2026
IV
2.25g
Q6h
T/C Sepsis Sec To CAPHR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: